Protein degraders enter the clinic—a new approach to cancer therapy

D Chirnomas, KR Hornberger, CM Crews - Nature Reviews Clinical …, 2023 - nature.com
Heterobifunctional protein degraders, such as PROteolysis TArgeting Chimera (PROTAC)
protein degraders, constitute a novel therapeutic modality that harnesses the cell’s natural …

Discovery of dabrafenib: a selective inhibitor of Raf kinases with antitumor activity against B-Raf-driven tumors

…, GM Adjabeng, KR Hornberger… - ACS medicinal …, 2013 - ACS Publications
Hyperactive signaling of the MAP kinase pathway resulting from the constitutively active B-Raf
V600E mutated enzyme has been observed in a number of human tumors, including …

Total synthesis of leucascandrolide A

KR Hornberger, CL Hamblett… - Journal of the American …, 2000 - ACS Publications
Leucascandrolide A (1) was isolated from the sponge Leucascandra caVeolata by Pietra
and co-workers in 1996. 1 The natural product displays strong in vitro cytotoxicity against KB …

Physicochemical property determinants of oral absorption for PROTAC protein degraders

KR Hornberger, EMV Araujo - Journal of Medicinal Chemistry, 2023 - ACS Publications
Heterobifunctional PROTAC degraders are gaining attention as a differentiated therapeutic
modality with the potential for oral dosing in the clinic. Belonging to the beyond Rule of Five …

Evidence for allosteric interactions of antagonist binding to the smoothened receptor

…, A Gilmartin, R Gontarek, KR Hornberger… - … of Pharmacology and …, 2009 - ASPET
The Smoothened receptor (Smo) mediates hedgehog (Hh) signaling critical for development,
cell growth, and migration, as well as stem cell maintenance. Aberrant Hh signaling …

Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding

…, HD Dickson, DF Hassler, KR Hornberger… - Bioorganic & medicinal …, 2009 - Elsevier
Hornberger a , Jeffrey R. Jackson b , Kevin W. Kuntz a , Timothy J. … KH Hornberger, JG
Badiang, JM Salovich, KW Kuntz, KA Emmitte, M. Cheung … Kuntz, K.; Salovich, J.; Mook, R.; …

Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors

AG Waterson, KG Petrov, KR Hornberger… - Bioorganic & Medicinal …, 2009 - Elsevier
Aniline ‘headgroups’ were synthesized and incorporated into an alkynyl thienopyrimidine
series of EGFR and ErbB-2 inhibitors. Potent inhibition of enzyme activity and cellular …

Room-Temperature Pd-Catalyzed Amidation of Aryl Bromides Using tert-Butyl Carbamate

…, GM Adjabeng, KR Hornberger - The Journal of …, 2009 - ACS Publications
The scope of Pd-catalyzed synthesis of N-Boc-protected anilines from aryl bromides and
commercially available tert-butyl carbamate is described. For the first time, this process can be …

A mild, one-pot synthesis of disubstituted benzimidazoles from 2-nitroanilines

KR Hornberger, GM Adjabeng, HD Dickson… - Tetrahedron …, 2006 - Elsevier
A one-pot synthesis of disubstituted benzimidazoles from 2-nitroanilines is described.
Hydrogenation of N-substituted 2-nitroanilines with palladium on carbon as catalyst in the …

Dual EGFR/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic thieno [3, 2-d] pyrimidines

…, RJ Griffin, MJ Reno, KR Hornberger… - Bioorganic & medicinal …, 2008 - Elsevier
A novel class of substituted pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines has been identified
that are potent and selective inhibitors of both EGFR/ErbB-2 receptor tyrosine kinases. …